QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (55) Citing Articles via Google Scholar Google Scholar Articles by Pedersen, W. A. Articles by Mattson, M. P. Search for Related Content PubMed PubMed Citation Articles by Pedersen, W. A. Articles by Mattson, M. P.

 Previous Article  |  Next Article 

The Journal of Neuroscience, January 15, 2002, 22(2):404-412

Urocortin, But Not Urocortin II, Protects Cultured Hippocampal Neurons from Oxidative and Excitotoxic Cell Death via Corticotropin-Releasing Hormone Receptor Type I

Ward A. Pedersen^{1, 2}, Ruiqian Wan¹, Peisu Zhang¹, and Mark P. Mattson^{1, 3}

¹ Laboratory of Neurosciences, Gerontology Research Center, National Institute on Aging, Baltimore, Maryland 21224, ² Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224, and ³ Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Urocortin and urocortin II are members of the corticotropin-releasing hormone (CRH) family of neuropeptides that function to regulate stress responses. Two high-affinity G-protein-coupled receptors have been identified that bind CRH and/or urocortin I and II, designated CRHR1 and CRHR2, both of which are present in hippocampal regions of mammalian brain. The hippocampus plays an important role in regulating stress responses and is a brain region in which neurons are vulnerable during disease and stress conditions, including cerebral ischemia, Alzheimer's disease, and anxiety disorders. Here we report that urocortin exerts a potent protective action in cultured rat hippocampal neurons with concentrations in the range of 0.5-5.0 pM, increasing the resistance of the cells to oxidative (amyloid -peptide, 4-hydroxynonenal, ferrous sulfate) and excitotoxic (glutamate) insults. We observed that urocortin is 10-fold more potent than CRH in protecting hippocampal neurons from insult, whereas urocortin II is ineffective. RT-PCR and sequencing analyses revealed the presence of both CRHR1 and CRHR2 in the hippocampal cultures, with CRHR1 being expressed at much higher levels than CRHR2. Using subtype-selective CRH receptor antagonists, we provide evidence that the neuroprotective effect of exogenously added urocortin is mediated by CRHR1. Furthermore, we provide evidence that the signaling pathway that mediates the neuroprotective effect of urocortin involves cAMP-dependent protein kinase, protein kinase C, and mitogen-activated protein kinase. This is the first demonstration of a biological activity of urocortin in hippocampal neurons, suggesting a role for the peptide in adaptive responses of hippocampal neurons to potentially lethal oxidative and excitotoxic insults.

Key words: antalarmin; cAMP; excitotoxicity; lipid peroxidation; sauvagine; stress

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/222404-09$05.00/0

This article has been cited by other articles:

				M.-J. Wang, S.-Z. Lin, J.-S. Kuo, H.-Y. Huang, S.-F. Tzeng, C.-H. Liao, D.-C. Chen, and W.-F. Chen Urocortin Modulates Inflammatory Response and Neurotoxicity Induced by Microglial Activation J. Immunol., November 1, 2007; 179(9): 6204 - 6214. [Abstract] [Full Text] [PDF]

				J. Xu, F. Xu, J. D. Hennebold, T. A. Molskness, and R. L. Stouffer Expression and Role of the Corticotropin-Releasing Hormone/Urocortin-Receptor-Binding Protein System in the Primate Corpus Luteum during the Menstrual Cycle Endocrinology, November 1, 2007; 148(11): 5385 - 5395. [Abstract] [Full Text] [PDF]

				R. A. Rissman, K.-F. Lee, W. Vale, and P. E. Sawchenko Corticotropin-Releasing Factor Receptors Differentially Regulate Stress-Induced Tau Phosphorylation J. Neurosci., June 13, 2007; 27(24): 6552 - 6562. [Abstract] [Full Text] [PDF]

				S. Kauser, A. Slominski, E. T. Wei, and D. J. Tobin Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides FASEB J, May 1, 2006; 20(7): 882 - 895. [Abstract] [Full Text] [PDF]

				E. W. Hillhouse and D. K. Grammatopoulos The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology Endocr. Rev., May 1, 2006; 27(3): 260 - 286. [Abstract] [Full Text] [PDF]

				G. C. Boorse, C. A. Kholdani, A. F. Seasholtz, and R. J. Denver Corticotropin-Releasing Factor Is Cytoprotective in Xenopus Tadpole Tail: Coordination of Ligand, Receptor, and Binding Protein in Tail Muscle Cell Survival Endocrinology, March 1, 2006; 147(3): 1498 - 1507. [Abstract] [Full Text] [PDF]

				C.-C. Huang, P.-H. Chou, C.-H. Yang, and K.-S. Hsu Neonatal isolation accelerates the developmental switch in the signalling cascades for long-term potentiation induction J. Physiol., December 15, 2005; 569(3): 789 - 799. [Abstract] [Full Text] [PDF]

				A. Chen, M. Perrin, B. Brar, C. Li, P. Jamieson, M. DiGruccio, K. Lewis, and W. Vale Mouse Corticotropin-Releasing Factor Receptor Type 2{alpha} Gene: Isolation, Distribution, Pharmacological Characterization and Regulation by Stress and Glucocorticoids Mol. Endocrinol., February 1, 2005; 19(2): 441 - 458. [Abstract] [Full Text] [PDF]

				B. K. Brar, A. Chen, M. H. Perrin, and W. Vale Specificity and Regulation of Extracellularly Regulated Kinase1/2 Phosphorylation through Corticotropin-Releasing Factor (CRF) Receptors 1 and 2{beta} by the CRF/Urocortin Family of Peptides Endocrinology, April 1, 2004; 145(4): 1718 - 1729. [Abstract] [Full Text] [PDF]

				B. K. Brar, A. K. Jonassen, E. M. Egorina, A. Chen, A. Negro, M. H. Perrin, O. D. Mjos, D. S. Latchman, K.-F. Lee, and W. Vale Urocortin-II and Urocortin-III Are Cardioprotective against Ischemia Reperfusion Injury: An Essential Endogenous Cardioprotective Role for Corticotropin Releasing Factor Receptor Type 2 in the Murine Heart Endocrinology, January 1, 2004; 145(1): 24 - 35. [Abstract] [Full Text] [PDF]

				F. Sananbenesi, A. Fischer, C. Schrick, J. Spiess, and J. Radulovic Mitogen-Activated Protein Kinase Signaling in the Hippocampus and Its Modulation by Corticotropin-Releasing Factor Receptor 2: A Possible Link between Stress and Fear Memory J. Neurosci., December 10, 2003; 23(36): 11436 - 11443. [Abstract] [Full Text] [PDF]

				E. Chatzaki, I. Charalampopoulos, C. Leontidis, I. A. Mouzas, M. Tzardi, C. Tsatsanis, A. N. Margioris, and A. Gravanis Urocortin in Human Gastric Mucosa: Relationship to Inflammatory Activity J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 478 - 483. [Abstract] [Full Text] [PDF]

				T. Perry, N. J. Haughey, M. P. Mattson, J. M. Egan, and N. H. Greig Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4 J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 881 - 888. [Abstract] [Full Text] [PDF]

				M. P. Mattson, S. L. Chan, and W. Duan Modification of Brain Aging and Neurodegenerative Disorders by Genes, Diet, and Behavior Physiol Rev, July 1, 2002; 82(3): 637 - 672. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help